Health Care: Drugs

Forest Laboratories Inc (FRX: NYSE)

$91.65 n/a | n/a%
04/23/14 - 04:01 PM ET
Company Income Statement
Mar 2013 Mar 2012 Mar 2011 Mar 2010
Sales 3.10B 4.57B 4.39B 4.11B
Cost of Sales 501.81M 876.23M 890.97M 837.84M
Gross Operating Profit 2.60B 3.69B 3.50B 3.27B
Selling, General, and Administrative Expenses 1.56B 1.55B 1.40B 1.26B
Research & Development 963.59M 796.93M 715.87M 1.05B
Operating Income before D & A (EBITDA) 73.26M 1.34B 1.38B 956.33M
Depreciation & Amortization 147.27M 121.86M 73.01M 86.51M
Interest Income 29.15M 20.36M 29.57M 35.47M
Other Income - Net 0.00 0.00 0.00 45.39M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -44.86M 1.24B 1.34B 950.69M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -44.86M 1.24B 1.34B 950.69M
Income Taxes -12.76M 258.63M 290.97M 268.30M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -32.10M 979.06M 1.05B 682.38M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -32.10M 979.06M 1.05B 682.38M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -32.10M 979.06M 1.05B 682.38M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-32.10M 979.06M 1.05B 682.38M
Preferred Dividends
Net Income Available To Common -32.10M 979.06M 1.05B 682.38M
Basic EPS from Continuing Ops. -0.12 3.58 3.60 2.25
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.12 3.58 3.60 2.25
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.12 3.58 3.60 2.25
Basic Normalized Net Income/Share -0.12 3.58 3.60 2.25
EPS fr Continuing Ops. -0.12 3.57 3.59 2.25
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.12 3.57 3.59 2.25
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.12 3.57 3.59 2.25
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.12 3.57 3.59 2.25
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with FRX

Latest FRX Headlines from TheStreet

More Financial News for FRX

Press Releases for FRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter